LifeVantage Corporation LFVN
4.56 USD -0.73 (-13.80%)
At closeNov 10, 2026, 4:00 PM EST
4.56 0.00 0.00%
After hours · Nov 10, 4:00 PM ET
4.56 Day range 5.31
3.90 52-week range 11.71
- YTD
- -25.97%
- 1 year
- -37.19%
News
seekingalpha.com LifeVantage Corporation (LFVN) Q1 2027 Earnings Call Transcript LifeVantage Corporation (LFVN) Q1 2027 Earnings Call Transcript
zacks.com Lifevantage (LFVN) Surpasses Q1 Earnings Estimates Lifevantage (LFVN) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.18 per share a year ago.
marketbeat.com What Lifevantage (LFVN) Said on Its Q1 Earnings Call Lifevantage NASDAQ: LFVN reported a 22% decline in revenue for its fiscal first quarter and outlined a strategy to overhaul its brand, digital sales tools and cost structure as it works to stabilize…
benzinga.com CORRECTION: Lifevantage Q1 Adj. EPS $0.05 Misses $0.06 Estimate, Sales $37.117M Miss $40.489M Estimate Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.06 by 16.67 percent. This is a 72.22 percent decrease over earnings of $0.18…
benzinga.com Lifevantage Q1 2027 Earnings Call Transcript Lifevantage (NASDAQ:LFVN) reported first-quarter financial results on Monday. The transcript from the company’s first-quarter earnings call has been provided below.This transcript is brought to you…
benzinga.com Lifevantage Q1 Adj. EPS $(0.02) Misses $0.06 Estimate, Sales $37.117M Miss $40.489M Estimate Lifevantage (NASDAQ:LFVN) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.06 by 133.33 percent. This is a 111.11 percent decrease over earnings of…
globenewswire.com LifeVantage Declares Quarterly Dividend SALT LAKE CITY, Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the…
globenewswire.com LifeVantage Announces Financial Results for the First Quarter Fiscal 2027 SALT LAKE CITY, Nov. 09, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the…
globenewswire.com New LifeVantage Research Explores How Protandim® Nrf2 Supports Cellular Defense Against Five Modern Environmental Toxins* SALT LAKE CITY, Oct. 29, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (Nasdaq: LFVN) continues to lead the next generation of healthy aging with its latest in vitro research study examining how…
defenseworld.net Lifevantage (NASDAQ:LFVN) Stock Breaks Above 200 Day Moving Average – What’s Next? Lifevantage Corporation (NASDAQ: LFVN - Get Free Report) crossed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $5.91 and traded…
globenewswire.com LifeVantage to Announce First Quarter Fiscal Year 2027 Results on November 9, 2026 SALT LAKE CITY, Oct. 26, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the…
zacks.com New Strong Sell Stocks for October 19th CWH, LFVN and CGAU have been added to the Zacks Rank #5 (Strong Sell) List on October 19, 2026.
globenewswire.com LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SALT LAKE CITY, Oct. 12, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that its Board of Directors granted inducement awards to…
marketbeat.com LifeVantage Unveils Turnaround Plan to Rebuild Brand, Margins and Growth Lifevantage NASDAQ: LFVN executives outlined a turnaround plan centered on strengthening the company's brand, improving consumer relevance and increasing operating efficiency during a Water Tower…
globenewswire.com LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026 SALT LAKE CITY, Sept. 18, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the…
benzinga.com Lake Street Maintains Hold on Lifevantage, Raises Price Target to $6 Lake Street analyst Ryan Meyers maintains Lifevantage (NASDAQ:LFVN) with a Hold and raises the price target from $5 to $6.
seekingalpha.com LifeVantage Corporation (LFVN) Q4 2026 Earnings Call Transcript LifeVantage Corporation (LFVN) Q4 2026 Earnings Call Transcript
marketbeat.com Lifevantage Q4 Earnings Call Highlights Lifevantage NASDAQ: LFVN reported lower fourth-quarter and fiscal 2026 results as the health and wellness company faced fewer orders, lower average order sizes and a difficult comparison against…
benzinga.com 12 Consumer Staples Stocks Moving In Thursday's After-Market Session Gainers Farmmi (NASDAQ:FAMI) shares rose 24.3% to $0.13 during Thursday's after-market session. The company's market cap stands at $3.8 million. IP Strategy Holdings (NASDAQ:IPST) stock moved upwards…
benzinga.com Lifevantage Q4 2026 Earnings Call Transcript On Thursday, Lifevantage (NASDAQ:LFVN) discussed fourth-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs.…
benzinga.com LifeVantage Plans To Not Issue FY27 Outlook Due To Recent CEO Transition LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced due to the recent…- benzinga.com Lifevantage Q4 Adj. EPS $0.11 Misses $0.13 Estimate, Sales $42.377M Miss $45.949M Estimate Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.13 by 15.38 percent. This is a 35.29 percent decrease over earnings of $0.17…
globenewswire.com LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026 SALT LAKE CITY, Aug. 27, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the…
globenewswire.com LifeVantage Declares Quarterly Dividend SALT LAKE CITY, Aug. 21, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the…
globenewswire.com LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2026 Results on August 27, 2026 SALT LAKE CITY, Aug. 13, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the…
globenewswire.com LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SALT LAKE CITY, Aug. 11, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”) today announced that its Board of Directors granted inducement awards to…- benzinga.com Lifevantage Names Terrence Moorehead As CEO LifeVantage Corporation (NASDAQ:LFVN) ("LifeVantage" or the "Company"), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today
globenewswire.com LifeVantage Welcomes Terrence Moorehead as Chief Executive Officer SALT LAKE CITY, Aug. 05, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate…- benzinga.com 12 Consumer Staples Stocks Moving In Monday's Pre-Market Session
zacks.com Do Options Traders Know Something About LifeVantage Stock We Don't? Investors need to pay close attention to LFVN stock based on the movements in the options market lately.
benzinga.com Why Did LifeVantage (LFVN) Stock Jump 27% After Hours? LifeVantage Corporation shares surged 27.01% in after-hours trading following strong short-squeeze momentum despite no immediate catalyst.- benzinga.com Lake Street Downgrades Lifevantage to Hold, Announces $5 Price Target Lake Street analyst Brooks O'Neil downgrades Lifevantage (NASDAQ:LFVN) from Buy to Hold and announces $5 price target.
benzinga.com Reported earlier, Lifevantage Sees Fiscal Year 2026 Revenue and Adjusted EPS Near Lower End Of Previously Issued Guidance Range; Prior Adj EPS Guidance $0.60-$0.80, Est. $0.67; Prior Sales Guidance $185M-$200M, Est. $192.831M Lifevantage (NASDAQ:LFVN) Sees Fiscal Year 2026 Revenue and Adjusted EPS Near Lower End Of Previously Issued Guidance Range; Prior Adj EPS Guidance $0.60-$0.80, Est. $0.67; Prior Sales Guidance…
benzinga.com Earnings Scheduled For May 6, 2026 
benzinga.com Lifevantage Q3 Adj. EPS $0.11 Misses $0.16 Estimate, Sales $43.716M Miss $47.767M Estimate Lifevantage (NASDAQ:LFVN) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.16 by 31.25 percent. This is a 57.69 percent decrease over earnings of $0.26…
benzinga.com Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - benzinga.com Earnings Scheduled For February 4, 2026
benzinga.com Earnings Scheduled For November 4, 2025 
benzinga.com American Outdoor Brands Posts Downbeat Results, Joins Lululemon, Quanex Building And Other Big Stocks Moving Lower In Friday's Pre-Market Session 
benzinga.com Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - benzinga.com Earnings Scheduled For September 4, 2025
benzinga.com Earnings Scheduled For May 6, 2025 
benzinga.com Why ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket 
benzinga.com Earnings Scheduled For February 5, 2025 - benzinga.com "Weight-Loss Drug Craze Appears To Be Curbing U.S. Obesity Epidemic; Obesity Is Down In The U.S. For The First Time In A Decade. A New Study Suggests Weight-Loss Drugs May Explain Why" - Bloomberg News https://www.bloomberg.com/news/articles/2024-12-13/ozempic-craze-appears-to-be-curbing-us-obesity-epidemic
- benzinga.com 'ADA Advises Against Using Compounded GLP-1 RA Medications' - Medscape https://www.medscape.com/viewarticle/ada-advises-against-using-compounded-glp-1-ra-medications-2024a1000m0u?form=fpf
- benzinga.com 12 Consumer Staples Stocks Moving In Friday's Intraday Session
- benzinga.com Market-Moving News for October 14th JSPR: 32% | Jasper Therapeutics shares are trading higher after the company announced it reported preliminary data from the Company's ongoing SPOTLIGHT Phase 1b/2a study of subcutaneous briquilimab…
- benzinga.com 12 Consumer Staples Stocks Moving In Monday's Pre-Market Session
- benzinga.com 12 Consumer Staples Stocks Moving In Thursday's After-Market Session